Adyn Analysis: $3M Raised
What is Adyn?
Adyn is a precision medicine company that creates personalized birth control solutions based on genetic risk and hormone profiles, aiming to minimize side effects.
Employees
7
Founded
2019
Revenue
$852.5k - $1.4M
Product Features & Capabilities
- personalized at-home birth control selection kit, assesses genetic risks and hormone profiles, minimizes side effects, includes collection materials and personalized lab results, virtual consultations available
Pricing
- The Birth Control Test: $369
- Includes free shipping
- HSA/FSA accepted
How much Adyn raised
1 - $2.5 million
April 2021Lead Investor: Lux Capital, M13, and others
Who are the founders of Adyn
ER
Elizabeth Ruzzo
Founder
Market Focus
Adyn primarily focuses on the healthcare industry, specifically in the area of reproductive health and personalized birth control solutions.
Investors
- 2c9 Ventures
- Anne Wojcicki
- Ascend Venture Capital
- Ashley Mayer
- Buffalo Ventures
- Lux Capital
- M13
- Civilization Ventures
- Concrete Rose Capital
- Y Combinator
- Madrona Pioneer
Competitors Overview
Adyn operates in the personalized birth control market, where its main competitors include:
- Nurx: This company offers a range of birth control options and provides online consultations for personalized prescriptions. Nurx emphasizes accessibility and convenience, allowing users to receive th
See something that needs updating? Suggest edits to this profile.